Austin Health, Melbourne, VIC, Australia.
Med J Aust. 2010 Aug 2;193(3):157-60. doi: 10.5694/j.1326-5377.2010.tb03836.x.
Cystic fibrosis (CF) carrier testing can be used to inform reproductive decision making, allowing carriers to avoid having a child with CF. A government-funded, population-based CF carrier screening program would allow greater equity of access to this test. The setting in which CF carrier screening is offered significantly affects the extent to which participants make well informed, voluntary decisions to accept or decline testing. Screening offered before pregnancy and in non-clinical environments better promotes participant autonomy than screening offered in the prenatal consultation.
囊性纤维化（CF）携带者检测可用于为生殖决策提供信息，使携带者能够避免生育 CF 患儿。政府资助的基于人群的 CF 携带者筛查计划将使更多人能够公平地获得这项检测。CF 携带者筛查的实施环境极大地影响了参与者做出知情、自愿接受或拒绝检测的程度。与在产前咨询中提供的筛查相比，在怀孕前和非临床环境中提供的筛查更能促进参与者的自主权。
